SCHEMBL14249761

SCHEMBL14249761

O=C(Cc1cccc2c1Cc1ccccc1-2)OCl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNMT P11086 1/20 0.54
▸ RAB9A P51151 4/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ HTR2B P41595 3/20 0.42
▸ HTR7 P34969 2/20 0.42
▸ DRD2 P14416 4/20 0.40
▸ DRD4 P21917 3/20 0.40
▸ DRD3 P35462 3/20 0.40
▸ HSP90AA1 P07900 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ SRD5A2 P31213 1/20 0.36
▸ HTR2C P28335 2/20 0.34
▸ ADRA1D P25100 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21437933 0.85 PNMT (0.54) PNMTRAB9ANPC1HTR2BHTR7
SCHEMBL11570811 0.83 PNMT (0.58) PNMTRAB9ANPC1HTR2BHTR7
SCHEMBL27813798 0.82 PNMT (0.50) PNMTRAB9ANPC1HTR2BHTR7
SCHEMBL225715 0.81 PNMT (0.60) PNMTRAB9ANPC1HTR2BHTR7
SCHEMBL1568269 0.81 PNMT (0.60) PNMTRAB9ANPC1HTR2BHTR7
SCHEMBL11204188 0.80 PNMT (0.63) PNMTRAB9ANPC1HTR2BHTR7
SCHEMBL21758216 0.80 PNMT (0.58) PNMTRAB9ANPC1HTR2BHTR7
SCHEMBL14975286 0.80 PNMT (0.51) PNMTRAB9ANPC1HTR2BHTR7
SCHEMBL28481867 0.78 MGLL (0.50) PNMTRAB9ANPC1
SCHEMBL31026685 0.78 PNMT (0.55) PNMTRAB9ANPC1HTR2BHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2721034-A1 TRICYCLIC ANTIBIOTICS Basilea Pharmaceutica AG (CH) 2014-04-23 — — EP disclosed
WO-2012171860-A1 TRICYCLIC ANTIBIOTICS BASILEA PHARMACEUTICA AG (CH) 2012-12-20 — — WO disclosed
Send feedback